Analgesics in Lebanon continues to outpace broader regional performance in 2026, projected to achieve retail value sales of LBP5.1 trillion, with growth of 9%, in an environment marked by high inflation, declining population and ongoing economic disruption. This robust outcome reflects the indispensability of pain relief in household health routines, the expansion of domestic supply networks and the rapid shift towards lower-cost generics and compact pack formats as purchasing power erodes. The environment remains attractive for operators that are able to respond to heightened price sensitivity and ensure product availability. For success, brands must streamline pack sizes, reinforce distribution through trusted pharmacy channels and leverage local production and targeted marketing, as traditional premium multinational brands lose share to agile domestic competitors.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Lebanon with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Lebanon, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Lebanon report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Lebanon?
- Which are the leading brands in Analgesics in Lebanon?
- How are products distributed in Analgesics in Lebanon?
- How has the regulatory and operating environment for Analgesics changed in Lebanon?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Affordable launches accelerate switch to generics
Domestic expansion secures supply as imports falter
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Self-medication to drive steady demand for affordable analgesics
Generics to outpace premium brands as price sensitivity intensifies
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Panadol underpins GSK Consumer Healthcare's clear lead
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies maintain leadership as regulatory trust shapes purchases
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!